The North America Dendritic Cell Cancer Vaccine Market represents a leading segment in the global cellular immunotherapy landscape, driven by high cancer incidence, world-class biotechnology infrastructure, and heavy investments in personalized medicine. Market expansion across the region is fueled by the growing clinical adoption of autologous cell therapies that harness antigen-presenting...